Heterozygous NTF4 Mutations Impairing Neurotrophin-4 Signaling in Patients with Primary Open-Angle Glaucoma

F Pasutto, T Matsumoto, CY Mardin, H Sticht, JH Brandstatter, K Michels-Rautenstrauss, N Weisschuh, E Gramer, Wishal Ramdas, Leonieke Koolwijk, Caroline Klaver, Hans Vingerling, BHF Weber, FE Kruse, B Rautenstrauss, YA Barde, A Reis

Research output: Contribution to journalArticleAcademicpeer-review

130 Citations (Scopus)


Glaucoma, a main cause of blindness in the developed world, is characterized by progressive degeneration of retinal ganglion cells (RGCs), resulting in irreversible loss of vision. Although members of the neurotrophin gene family in various species are known to support the survival of numerous neuronal populations, including RGCs, it is less clear whether they are also required for survival and maintenance of adult neurons in humans. Here, we report seven different heterozygous mutations in the Neurotrophin-4 (NTF4) gene accounting for about 1.7% of primary open-angle glaucoma patients of European origin. Molecular modeling predicted a decreased affinity of neurotrophin 4 protein (NIT-4) mutants with its specific tyrosine kinase receptor B (TrkB). Expression of recombinant NT-4 carrying the most frequent mutation was demonstrated to lead to decreased activation of TrkB. These findings suggest a pathway in the pathophysiology of glaucoma through loss of neurotrophic function and may eventually open the possibility of using ligands activating TrkB to prevent the progression of the disease.
Original languageUndefined/Unknown
Pages (from-to)447-456
Number of pages10
JournalAmerican Journal of Human Genetics
Issue number4
Publication statusPublished - 2009

Cite this